ArticleAmerican journal of hematology2026

Basiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study.

Zhenbin Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.